This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cigna (CI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $281.16 in the latest trading session, marking a -0.57% move from the prior day.
MGIC Investment Corporation (MTG) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
MGIC (MTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cigna (CI) to Add Three Biosimilars to NPF, Enable Cost Savings
by Zacks Equity Research
Cigna (CI) plans to integrate three cost-effective biosimilars within NPF in a bid to offer varied treatment options for Americans and solidify its pharmacy business.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $280.75, moving +0.15% from the previous trading session.
Are Investors Undervaluing Cigna Group (CI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
If You Invested $1000 in Cigna a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
The Zacks Analyst Blog Highlights Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group
by Zacks Equity Research
Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group are part of the Zacks top Analyst Blog.
Top Analyst Reports for Apple, Verizon & Amgen
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Verizon Communications Inc. (VZ) and Amgen Inc. (AMGN).
Cigna (CI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $274.74, marking a -0.38% move from the previous day.
Here is What to Know Beyond Why Cigna Group (CI) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Cigna (CI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UnitedHealth's (UNH) Optum Rx Makes Patient Care Affordable
by Zacks Equity Research
UnitedHealth Group, Inc's. (UNH) Optum Rx is set to offer three biosimilar alternatives for HUMIRA effective Jul 1, providing affordability in patient care.
Cigna (CI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $275.33, moving +0.55% from the previous trading session.
Is the Options Market Predicting a Spike in Cigna (CI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cigna (CI) stock based on the movements in the options market lately.
Here's Why Investors Should Hold Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Cigna (CI) Stock Moves -0.24%: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $268.83, marking a -0.24% move from the previous day.
Cigna Group (CI) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Cigna (CI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group
by Zacks Equity Research
Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group are part of the Zacks top Analyst Blog.
Top Research Reports for Johnson & Johnson, Oracle & HSBC
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle Corporation (ORCL) and HSBC Holdings plc (HSBC).
Why Cigna (CI) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cigna (CI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $265.88, moving +0.52% from the previous trading session.
Here's Why Cigna (CI) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Industry Outlook Highlights UnitedHealth Group, The Cigna Group, Humana, Centene Corporation and Molina Healthcare
by Zacks Equity Research
UnitedHealth Group, The Cigna Group, Humana, Centene Corporation and Molina Healthcare are part of the Zacks Industry Outlook article.
5 HMO Industry Stocks to Watch as Technology Expenses Take a Toll
by Debasmita Chatterjee
The Medical-HMO industry is witnessing growth in customer base and an active M&A strategy. However, high technology expenses and medical personnel shortage raise concerns. UNH, CI, HUM, CNC and MOH are likely to navigate the industry storms.
Cigna (CI) Inks Deal With CHSS to Enhance Specialty Care
by Zacks Equity Research
Cigna (CI) partners with CarepathRx Health System Solutions to accelerate the delivery of pharmacy care for patients with complex needs.
Cigna Group (CI) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Cigna (CI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.